rfhg_225584.1

Basic information about the TSS

---

TSS ID: rfhg_225584.1 Species: human Chr: chr21		Start: 33542779 End: 33542793 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3336512,EH38E2138126)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000426819.5:0 GeneID: 2618 HGNC/MGI_ID: HGNC:4163 UniProt_ID: C9JBJ1 Nearer transcript ids and distances: AB208785:-26 ENST00000438059.5:-27 AK292560:-35 BX648124:-37 ENST00000381831.7:-49 ENST00000381839.7:-68 NM_001136005.1:-96 BC068438:-96 ENST00000424203.5:-99 NM_001136006.1:-99 ENST00000441403.1:416 view more...

Gene_name: phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase Gene_symbol: GART Gene_synonyms: GARS-AIRS-GART Gene_source: HGNC:4163

TATA-Box annotation

---

Distance to TSS:	103
Nearest PromoterID:	NM_001136005
Entrez ID:	2618
Nearest Unigene:	Hs.473648
Nearest Refseq:	NM_000819
Nearest Ensembl:	ENSG00000159131
Gene Name:	phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
Gene Alias:	AIRS|GARS|GARTF|PAIS|PGFT|PRGS
Gene Type:	protein-coding
CpG%:	0.071429
GC%:	0.466667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GART p2@GART p3@GART p4@GART p5@GART
Sample		p1@GART	p2@GART	p3@GART	p4@GART	p5@GART
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	98.57	8.18	8.38	5.06	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	89.42	6.88	6.27	4.65	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	103.40	5.40	9.65	5.40	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	88.99	5.20	6.03	4.57	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	96.29	6.97	9.67	3.15	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	100.78	5.04	7.56	3.68	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	134.00	7.84	6.75	3.05	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	116.75	5.57	6.06	4.12	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	117.33	5.98	5.77	2.99	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	79.41	6.96	11.01	2.90	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	78.02	8.89	10.51	6.47	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	91.07	8.94	11.38	8.94	4.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.60	4.19	1.45	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	21.95	3.76	1.50	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.08	2.63	0.88	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	17.10	2.51	3.52	1.01	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	20.53	2.18	1.75	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	16.45	1.27	1.27	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	3.20	2.67	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	21.06	4.51	2.71	0.75	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	24.59	4.28	2.41	0.94	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.17	4.66	2.59	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	20.03	2.20	1.68	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.63	2.67	1.94	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.45	2.58	1.03	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.16	3.80	2.53	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	3.85	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.75	1.89	1.18	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	16.96	2.58	1.62	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	22.80	2.71	1.63	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.96	2.09	1.88	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	18.95	2.74	0.59	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.41	3.38	2.32	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	26.39	4.78	2.47	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	20.76	2.43	2.24	0.75	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	19.55	2.11	1.53	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.73	2.04	1.84	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	18.13	1.01	1.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	19.72	4.32	1.89	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	20.17	1.92	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	20.00	3.53	1.88	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	22.69	3.51	1.90	0.88	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.40	2.32	0.84	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.88	3.67	1.22	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	18.27	3.01	2.21	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.57	3.26	1.63	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.23	2.64	2.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.78	2.38	2.09	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.67	3.11	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.45	3.84	2.63	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.98	3.89	2.46	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	26.02	4.89	1.78	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	21.29	2.48	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.57	1.33	2.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	69.63	10.91	8.39	5.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	29.85	10.10	4.13	1.84	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	17.50	1.94	2.59	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.34	1.61	2.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	35.83	6.92	3.46	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	2.12	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	1.68	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	46.18	8.76	3.18	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.88	3.40	4.76	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	21.12	2.60	2.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.68	2.13	1.06	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	0.49	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.27	1.98	0.00	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	0.00	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.76	0.66	1.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	23.51	2.17	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	24.15	1.22	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	22.81	1.58	0.95	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	20.53	1.76	1.12	0.16	0.32
Adipocyte - omental, donor1	11473-119C6	19.47	2.16	1.65	0.51	0.00
Adipocyte - omental, donor2	11474-119C7	17.19	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	19.43	2.34	1.34	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	13.40	3.19	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	3.30	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	44.26	2.71	0.90	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	20.33	2.78	1.04	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	29.73	3.91	1.37	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	19.05	0.00	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	27.32	2.23	0.84	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	32.33	2.94	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.32	3.70	1.45	0.48	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	23.88	1.94	0.97	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	18.66	1.07	2.13	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	1.11	1.67	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	22.04	3.74	2.08	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	24.11	1.76	1.26	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	19.31	1.96	2.62	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.61	2.74	1.22	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	44.86	0.88	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	5.38	1.79	1.08	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	27.35	1.62	0.18	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.44	1.44	0.41	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	25.29	4.69	1.26	0.57	0.11
Anulus Pulposus Cell, donor2	11463-119B5	13.71	5.14	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.26	1.35	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.71	0.87	0.87	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.34	3.29	0.30	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	0.00	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.87	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	26.21	1.94	1.46	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	1.78	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	20.72	1.88	0.38	0.38	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	1.25	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.29	2.14	0.66	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	2.73	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.82	2.41	0.75	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.25	0.54	1.61	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	18.89	1.13	0.57	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.97	2.14	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	18.53	1.95	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.56	1.99	1.33	0.17	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.76	1.89	0.51	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.30	0.97	1.94	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.77	2.28	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.95	1.71	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.67	2.14	1.07	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	1.29	0.52	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	1.88	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	1.93	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.04	1.17	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.48	1.81	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.78	1.53	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.10	2.04	1.53	0.76	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.99	2.16	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.26	1.91	1.48	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.50	2.32	0.87	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	22.21	2.03	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	4.63	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.30	1.50	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	14.44	1.20	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.85	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	21.61	1.61	0.92	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.46	1.78	1.27	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	22.09	1.86	0.21	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.46	0.92	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.38	2.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.07	0.89	0.67	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.72	1.66	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.89	1.32	1.06	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.90	1.45	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	41.14	4.67	1.84	0.74	0.37
Astrocyte - cerebellum, donor2	11580-120F5	19.51	1.71	1.03	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	11.12	2.31	2.52	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	70.07	4.88	2.09	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	48.05	3.40	2.26	0.16	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	56.83	1.94	1.64	0.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	96.22	10.90	3.56	1.03	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	115.76	10.15	4.89	1.63	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	99.80	10.81	4.21	1.59	0.11
Basophils, donor1	12241-129G9	6.28	9.15	11.25	3.14	0.52
Basophils, donor2	12242-129H1	9.02	10.46	7.58	6.13	0.72
Basophils, donor3	12243-129H2	7.35	4.85	4.56	2.20	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	19.84	1.08	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	41.43	1.26	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	47.00	2.29	0.83	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	37.08	1.84	0.92	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	38.51	1.62	0.54	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	94.81	10.10	3.19	1.13	2.37
Burkitt's lymphoma cell line:RAJI	10476-106I8	118.32	7.92	3.49	1.16	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	50.20	13.11	7.67	3.52	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.94	8.45	10.14	8.45	0.00
CD14+ Monocytes, donor2	11305-117B9	4.08	10.02	8.72	5.75	0.56
CD14+ Monocytes, donor3	11381-118B4	5.49	13.39	10.10	3.51	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	23.49	4.53	1.13	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	25.78	4.93	1.14	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	32.87	1.64	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	8.53	4.91	2.89	1.30	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	9.66	6.03	0.91	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	10.90	5.69	1.90	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.52	5.36	3.18	0.67	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.48	3.86	4.42	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.71	7.69	4.96	1.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.52	2.55	5.48	1.17	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.38	4.99	4.10	1.96	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.44	8.71	8.27	2.39	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.81	7.96	8.19	3.28	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	6.86	6.34	5.81	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	3.33	11.09	4.44	2.22	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.16	6.40	4.91	1.04	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.98	5.39	5.19	2.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	6.45	8.33	5.62	1.04	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.29	5.49	5.03	1.83	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.66	9.27	7.01	3.39	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	8.73	7.42	3.49	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	3.50	3.77	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.41	4.54	4.54	1.40	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.42	6.73	5.47	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.31	5.14	3.49	1.29	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.17	3.87	4.23	2.11	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.70	8.77	7.02	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.09	4.53	3.84	1.74	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.60	4.46	2.23	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.47	8.41	6.25	2.80	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.50	2.05	3.28	0.82	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.17	6.49	3.94	3.01	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.62	8.58	8.12	3.48	1.16
CD14+CD16+ Monocytes, donor1	11789-124B7	21.14	6.32	5.67	1.53	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	19.40	8.78	5.31	3.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	19.93	6.93	5.63	3.03	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	21.02	11.06	3.74	1.56	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	14.67	7.34	4.89	1.22	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	22.07	9.59	3.57	1.78	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	17.61	6.12	6.38	2.04	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	18.44	6.37	3.95	1.32	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	22.95	8.63	4.42	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	18.29	8.13	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	42.71	12.88	5.42	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	38.32	8.28	8.28	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	43.18	12.26	6.93	1.07	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	39.13	17.15	9.11	1.07	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	36.50	17.55	2.81	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	30.59	10.98	6.27	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	11.86	11.86	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	17.26	13.97	7.40	2.47	4.11
CD19+ B Cells, donor2	11624-122B4	11.61	13.78	2.18	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	14.64	13.13	4.04	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	142.23	10.10	7.68	2.83	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	102.67	3.99	2.80	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	14.06	5.02	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	7.87	5.06	2.25	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	74.40	8.27	2.63	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	86.13	9.70	6.54	0.90	0.90
CD4+ T Cells, donor1	11225-116C1	17.50	14.28	5.00	5.00	3.21
CD4+ T Cells, donor2	11306-117C1	7.35	17.15	9.19	0.61	1.84
CD4+ T Cells, donor3	11382-118B5	13.11	21.96	8.54	3.96	5.49
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.22	5.10	4.85	0.77	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	42.67	6.51	3.59	2.02	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	43.98	7.19	3.45	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	34.61	24.18	8.53	2.84	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	34.41	30.90	10.53	4.21	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	29.67	16.48	6.59	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.27	8.09	4.34	1.30	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.42	5.08	2.37	1.19	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	32.40	5.16	2.58	1.13	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	27.35	12.10	5.38	0.90	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	31.10	17.82	7.69	1.75	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.92	22.00	7.04	3.08	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.48	8.85	3.37	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.96	4.36	2.29	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.06	5.01	1.34	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	29.91	21.48	9.52	2.72	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	40.73	21.97	9.65	0.54	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	26.90	10.76	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	48.40	5.38	2.97	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	50.26	5.20	1.95	0.22	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	43.50	5.04	2.73	1.47	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	25.79	15.67	12.13	1.01	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	25.13	23.40	9.53	3.47	4.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.97	22.66	6.10	3.92	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.91	18.31	4.95	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	53.54	11.08	7.39	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	25.12	9.77	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	68.12	12.74	6.37	0.55	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	76.56	16.69	7.85	1.23	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	21.56	9.24	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	36.89	14.32	3.22	1.07	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	45.70	15.23	6.92	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	15.39	18.66	14.08	3.93	3.93
CD8+ T Cells, donor2	11307-117C2	6.38	16.14	9.76	3.00	1.13
CD8+ T Cells, donor3	11383-118B6	12.12	21.71	13.38	3.79	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	60.10	4.13	1.84	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	46.97	3.83	2.16	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	45.69	2.74	1.64	0.82	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	75.95	4.50	3.30	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	48.48	2.16	1.68	0.48	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	49.12	1.36	2.96	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	73.88	1.30	2.61	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	62.12	1.58	1.84	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	61.68	3.52	2.81	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	62.49	3.62	2.72	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.00	3.49	2.91	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	66.61	2.93	1.60	0.27	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	37.21	2.63	2.19	0.44	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	40.99	2.28	0.46	0.91	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	34.31	4.48	2.98	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.94	0.72	2.52	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.35	1.73	0.86	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	47.85	4.24	2.12	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	85.25	1.90	0.63	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	79.04	3.08	1.85	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	73.09	0.96	0.32	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	62.72	5.74	3.44	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	63.84	4.34	0.79	1.18	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	62.03	5.29	2.27	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	16.06	8.83	4.82	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	46.16	10.49	9.79	6.29	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	5.01	3.01	4.01	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	1.48	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	36.41	2.32	0.32	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	39.17	2.77	1.39	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	25.94	1.78	1.78	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	26.17	1.82	0.57	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	68.93	3.58	2.69	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	21.84	3.64	5.26	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	49.46	4.13	2.18	0.69	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	33.77	3.21	0.21	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	38.23	3.54	1.33	0.35	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	22.47	11.74	17.51	6.42	1.01
Corneal Epithelial Cells, donor1	11526-119I5	16.69	0.22	0.00	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	13.65	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	25.82	1.02	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	20.97	2.81	0.33	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.71	4.73	0.32	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.60	1.30	1.30	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	12.30	8.20	3.42	0.68	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.67	14.36	5.88	1.96	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.42	10.16	3.39	4.36	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	43.69	2.33	2.50	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	32.86	0.59	1.17	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	35.92	1.13	0.57	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	20.45	0.39	1.97	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	19.49	1.75	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	29.65	2.35	0.71	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	39.97	2.45	1.05	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.04	1.99	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	27.69	1.83	1.22	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	32.98	2.26	1.69	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	31.79	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	36.45	1.56	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	14.60	0.99	0.71	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	64.82	2.40	0.80	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	20.44	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	77.28	2.86	0.50	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.85	0.87	0.22	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.49	1.47	0.49	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	37.54	2.28	2.28	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	36.32	4.19	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	27.01	1.88	0.94	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	28.05	14.85	11.55	1.65
Eosinophils, donor3	12246-129H5	3.57	7.13	21.40	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.81	1.22	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.76	2.05	0.82	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.35	0.55	0.11	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.38	2.38	0.65	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.96	2.91	1.33	0.00	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	77.11	5.19	2.73	1.09	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	19.62	1.48	0.42	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	61.13	5.53	2.90	1.58	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.89	2.99	1.99	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	33.57	4.08	1.36	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	21.98	4.55	1.52	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	12.46	0.79	0.32	0.00	0.47
Fibroblast - Cardiac, donor4	11452-119A3	36.37	5.15	1.82	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	43.53	1.40	0.89	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	39.41	2.12	0.45	0.61	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.82	4.56	1.47	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.14	2.59	1.29	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	77.63	4.39	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	37.59	2.31	1.85	0.92	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	23.41	4.41	1.70	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	38.03	1.41	0.47	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	62.73	1.89	1.42	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	36.27	1.09	0.36	0.73	0.00
Fibroblast - Dermal, donor4	11450-119A1	75.29	1.81	0.79	0.45	0.11
Fibroblast - Dermal, donor5	11454-119A5	75.36	2.79	1.05	1.22	0.17
Fibroblast - Dermal, donor6	11458-119A9	85.11	2.27	1.46	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	48.10	1.46	1.04	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.72	2.88	0.79	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	64.97	2.50	1.98	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	27.27	3.29	1.16	0.77	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	1.04	3.12	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.26	1.59	0.53	0.88	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.45	2.49	1.09	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	35.84	1.49	1.08	0.41	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.94	1.41	0.71	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	26.18	2.78	0.88	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.77	3.14	2.05	0.27	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	37.62	2.30	1.86	0.66	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.29	3.37	2.20	0.73	0.15
Fibroblast - Lung, donor1	11270-116H1	28.55	4.08	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	55.21	5.97	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	33.55	1.90	1.27	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	32.49	0.83	1.67	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.00	0.84	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	68.20	2.84	0.81	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	65.56	3.10	0.39	0.39	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	66.44	1.97	0.61	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	78.94	2.75	0.92	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	24.81	1.14	0.76	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	2.97	0.81	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.25	1.74	0.81	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	47.42	1.22	0.00	0.44	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.34	2.03	0.81	0.61	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	18.71	1.34	0.00	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.30	1.58	0.00	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	74.42	5.16	1.59	1.19	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	22.38	3.55	1.07	0.53	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.73	2.37	0.79	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	53.55	4.51	1.20	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	44.15	4.43	1.40	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	80.98	9.36	1.77	0.51	0.51
Fibroblast - skin normal, donor1	11553-120C5	30.03	3.28	1.97	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	84.61	4.41	2.01	0.80	0.40
Fibroblast - skin normal, donor2	11561-120D4	37.67	3.21	1.11	0.40	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	88.56	8.16	2.42	0.60	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	25.43	3.40	1.33	0.25	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	33.68	4.79	2.05	1.37	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	49.26	3.28	1.31	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.30	3.09	1.07	0.53	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	37.11	2.53	1.18	1.01	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.84	3.45	1.57	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	354.56	44.32	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	28.76	4.36	1.74	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	30.16	1.73	1.21	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	45.54	1.04	0.78	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.71	2.04	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	65.84	6.12	3.06	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	67.00	7.66	5.74	1.91	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	124.09	9.41	7.70	2.57	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.29	6.34	4.69	1.65	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	40.41	7.53	5.71	1.83	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	79.25	6.34	3.76	1.59	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	41.50	6.34	3.17	0.79	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.72	11.74	6.52	0.65	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	99.94	9.29	6.63	2.21	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	79.14	3.25	2.12	0.14	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	59.72	4.43	1.60	0.62	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	59.90	2.69	1.61	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.55	2.48	1.36	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	59.11	2.63	1.52	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	60.58	3.05	0.61	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.88	5.25	1.14	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.10	3.74	1.62	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	43.28	1.53	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.32	6.50	1.48	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.87	4.45	1.43	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.55	2.68	1.12	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	32.87	3.43	1.21	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.65	3.39	1.19	0.17	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	59.32	4.79	1.15	0.35	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.80	5.31	1.46	0.62	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.26	5.64	1.20	1.20	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	40.17	3.43	1.33	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.50	3.41	1.75	0.25	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.17	5.10	1.43	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.36	2.89	1.44	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	37.93	4.50	1.38	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.35	1.83	1.50	0.67	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.45	3.53	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.42	3.94	0.98	0.61	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.96	3.73	1.46	0.65	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.94	3.85	0.64	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	30.80	1.80	0.76	0.66	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	33.85	1.74	0.79	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.88	1.82	1.22	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	31.57	3.24	0.94	0.31	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.10	2.63	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.29	3.37	0.56	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	34.07	2.78	0.65	0.28	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	30.22	1.34	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	32.90	1.84	0.77	0.46	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	39.77	1.81	0.52	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.48	1.08	0.81	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	26.55	3.50	0.74	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.76	2.63	1.97	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	1.98	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.74	2.64	1.32	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.18	2.82	0.40	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	20.08	4.32	0.25	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	157.26	6.97	4.78	1.39	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	97.84	5.85	2.16	0.62	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	128.07	6.55	1.64	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	55.39	5.01	1.88	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	70.92	5.09	3.67	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	81.63	5.53	3.69	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	61.87	7.42	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	68.85	5.03	3.87	3.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	4.81	4.81	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	41.73	8.69	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	58.26	3.58	3.58	0.98	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	59.71	5.35	2.47	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	44.74	5.31	0.84	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	56.54	4.90	2.94	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	0.84	2.52	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.30	5.73	3.50	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.23	2.72	3.40	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	43.85	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	48.68	2.29	1.72	1.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.09	3.85	0.89	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	1.69	8.47	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.33	4.97	2.90	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	45.80	5.29	1.84	1.38	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	41.90	5.38	1.54	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.40	7.50	5.22	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	37.46	6.02	4.68	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	41.99	3.47	1.16	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	43.13	5.14	2.74	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	27.33	2.48	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.67	4.25	1.42	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	34.40	3.62	1.21	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	39.68	4.58	2.03	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	35.90	8.38	1.60	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.04	3.45	3.45	0.49	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	5.90	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	5.83	0.58	2.33	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.13	5.71	2.63	2.63	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	25.43	7.63	3.39	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	21.49	2.98	1.79	2.39	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	31.06	9.22	2.91	2.43	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	29.67	0.00	3.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	0.83	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	6.75	6.75	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.86	1.27	1.59	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.95	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	69.51	1.16	1.16	0.58	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	63.47	2.19	0.68	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	76.67	1.82	1.82	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	64.71	1.75	0.66	0.66	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	62.97	1.50	1.07	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	72.55	1.72	1.08	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.16	1.99	0.75	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	58.67	1.89	0.86	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	53.82	0.96	1.60	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.67	1.68	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.22	1.73	0.87	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	39.66	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	21.16	2.12	0.00	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	2.18	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.09	1.22	1.05	0.00	0.00
Hepatocyte, donor1	11523-119I2	36.32	4.84	1.21	1.21	1.21
Hepatocyte, donor2	11603-120I1	45.25	3.23	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	28.22	3.07	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	69.84	26.76	10.44	2.61	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	50.34	4.02	1.22	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.48	1.10	0.69	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	168.75	9.55	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	6.68	20.03	6.68	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	139.82	8.31	19.38	4.15	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	127.64	10.01	12.51	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	142.42	11.87	11.87	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	151.21	30.75	12.81	12.81	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	150.84	4.57	9.14	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	201.42	17.87	24.36	6.50	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	163.40	18.34	10.00	8.34	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	141.59	10.89	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	199.84	19.85	21.18	5.29	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	167.41	9.98	7.76	5.54	3.33
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	167.63	31.43	36.67	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	183.29	11.34	11.34	5.04	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	171.68	7.73	9.28	3.09	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	14.63	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	200.27	13.57	12.27	4.52	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	228.61	16.10	8.05	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	23.90	11.95	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	252.61	13.85	14.67	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	218.72	6.72	7.56	2.52	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	172.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	196.90	14.47	9.64	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	140.34	8.31	5.54	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	166.63	9.44	4.72	1.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	168.70	9.07	4.53	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	175.41	11.84	9.69	5.38	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	184.22	5.08	3.81	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	0.00	32.86	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	183.01	9.57	9.57	3.83	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	133.05	3.65	5.47	3.65	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	0.00	0.00	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	177.80	7.14	4.28	5.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	162.60	19.91	9.95	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	134.88	6.17	6.48	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	159.80	8.78	14.05	5.27	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	179.16	9.43	15.72	12.57	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	168.98	8.34	11.13	4.87	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	154.92	2.21	8.85	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	145.89	6.48	6.48	9.73	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	134.28	4.36	6.10	2.62	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	132.74	2.25	9.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	160.29	10.45	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	145.08	4.27	5.33	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	142.70	5.54	2.77	5.54	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	168.13	8.55	11.40	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	166.60	5.52	7.36	5.52	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	108.91	6.05	3.03	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	111.76	6.21	12.42	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	95.16	6.34	4.23	6.34	0.00
Keratinocyte - epidermal, donor1	11272-116H3	37.21	1.96	0.24	0.16	0.16
Keratinocyte - epidermal, donor2	11349-117G8	50.36	2.93	0.59	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	61.05	1.23	0.28	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	86.27	4.20	1.25	0.68	0.23
Keratocytes, donor1	11527-119I6	35.41	1.03	1.03	0.69	0.00
Keratocytes, donor2	11607-120I5	16.41	2.34	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	34.18	1.38	0.99	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	26.97	2.16	2.16	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	33.68	4.38	0.92	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	41.98	2.32	0.81	0.30	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	39.25	1.07	0.71	0.24	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	18.42	1.95	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.69	2.68	0.79	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	1.61	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	19.23	2.21	0.63	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	22.10	1.29	0.65	0.43	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.75	1.23	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	13.91	1.01	1.26	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.96	0.84	0.84	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.19	1.98	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.84	1.36	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	16.66	1.67	0.93	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.00	1.05	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.99	0.72	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.58	0.82	0.82	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	0.62	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.64	1.25	1.25	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.70	0.91	0.55	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.05	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.11	2.34	0.59	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	24.15	1.99	1.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	0.48	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.77	1.08	1.62	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	22.10	1.21	0.91	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	24.88	2.07	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.33	0.42	0.63	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	20.45	0.90	0.60	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	20.64	0.69	1.38	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.56	1.88	0.75	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.56	1.80	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	1.98	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.70	0.99	0.74	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.99	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	17.54	0.74	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.62	0.69	1.24	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	29.91	0.96	0.96	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.69	1.52	0.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.59	1.54	0.56	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.33	1.78	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.63	1.45	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.25	1.09	1.09	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	26.14	0.72	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.89	0.98	0.98	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	0.94	0.47	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	39.97	1.24	0.87	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.32	0.26	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.78	1.19	1.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	18.13	4.53	9.06	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	13.81	6.90	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	9.65	8.91	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.23	15.23	5.50	5.92	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	11.25	1.41	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	11.21	7.47	5.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	14.94	9.79	4.64	3.61	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	5.95	3.57	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.68	12.21	4.98	2.04	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	23.85	12.80	3.20	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.61	14.86	5.40	3.60	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	27.23	12.19	8.54	1.22	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	15.92	15.41	10.78	3.08	4.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	20.47	5.65	4.23	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	13.33	6.00	4.66	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.38	10.70	9.17	4.58	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	6.14	4.27	1.60	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	21.73	6.42	4.16	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.79	13.50	11.04	3.68	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	29.36	18.75	4.89	4.89	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.24	7.71	3.54	0.62	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	18.50	8.69	3.92	1.12	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	21.64	8.24	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	25.26	6.97	4.35	0.29	1.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	18.53	10.46	5.98	0.30	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.00	8.85	3.87	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	26.51	17.32	7.42	2.83	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	8.48	7.01	1.84	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	13.82	11.51	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	21.11	10.36	4.61	1.54	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	20.38	9.06	2.83	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	12.31	9.03	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	20.79	11.75	5.42	2.26	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.93	9.34	5.03	2.87	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	8.96	5.98	2.24	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	23.41	10.03	7.06	1.86	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.49	12.49	4.74	2.58	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	12.84	5.99	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.99	13.99	8.00	2.67	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	21.12	18.10	9.65	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	13.51	10.66	5.69	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	23.03	14.09	7.22	2.75	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.64	18.79	9.66	3.22	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	9.43	4.71	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	19.26	12.59	8.15	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	10.47	16.28	13.96	1.16	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	31.73	13.75	9.52	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	20.41	14.01	6.80	0.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	29.80	9.45	8.00	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	27.59	11.50	3.83	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	22.20	20.22	12.83	3.95	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	26.35	14.11	0.94	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	19.11	12.07	4.02	3.52
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	22.08	18.48	9.46	3.15	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	13.77	10.33	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.93	17.81	14.70	3.56	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.38	13.69	13.29	5.47	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	11.88	10.56	1.32	3.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	12.45	6.75	2.59	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	26.69	11.81	8.31	3.06	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.36	13.98	6.15	4.47	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	11.92	5.74	3.97	2.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	15.81	10.80	4.63	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	22.28	12.15	4.56	1.52	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	22.59	12.02	4.81	1.92	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	23.46	10.73	7.16	4.77	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	24.30	9.11	7.90	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	13.83	4.15	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.90	9.50	5.70	0.76	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	21.69	10.84	7.23	3.61	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	31.44	13.30	4.23	2.42	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	23.77	8.87	4.75	2.54	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	24.52	13.86	8.00	2.67	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	14.94	6.90	3.45	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.74	9.77	9.26	4.63	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	14.15	4.24	2.83	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	12.48	6.81	2.84	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.97	9.98	7.49	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	14.09	8.61	3.13	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.47	10.86	3.76	2.51	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.95	10.22	5.58	1.39	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	20.07	6.02	4.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	30.47	13.37	5.35	2.67	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	35.96	12.53	5.25	2.83	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	16.52	13.77	8.26	3.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	31.12	16.89	5.33	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.21	16.53	9.12	0.57	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	28.38	15.34	10.74	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	27.36	8.75	6.02	1.64	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.08	11.58	8.46	0.45	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	37.95	11.44	5.72	2.34	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.87	17.24	7.29	2.65	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	14.55	8.31	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	20.74	1.60	0.46	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	21.65	1.10	0.92	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	16.52	1.44	0.39	0.39	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	22.83	0.53	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	39.77	3.01	0.95	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	60.32	1.67	0.97	0.42	0.14
Mammary Epithelial Cell, donor1	11273-116H4	96.26	4.09	2.29	0.70	0.20
Mammary Epithelial Cell, donor2	11350-117G9	79.63	5.79	0.87	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	39.66	1.25	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	73.22	2.71	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	34.93	2.81	1.95	0.43	0.22
Mast cell, donor2	11565-120D8	17.53	6.24	5.94	1.49	0.59
Mast cell, donor3	11566-120D9	18.69	13.28	12.83	2.93	1.80
Mast cell, donor4	11567-120E1	13.83	6.74	9.40	4.43	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	43.69	5.88	3.44	0.44	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	41.44	4.09	4.09	1.17	1.17
Mast cell, expanded, donor5	11939-126A4	28.22	3.56	1.72	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	20.25	5.19	2.85	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	47.76	2.09	0.40	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	22.15	1.73	1.04	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	63.02	1.67	1.09	0.22	0.22
Melanocyte - light, donor1	11274-116H5	28.91	1.88	0.47	0.71	0.00
Melanocyte - light, donor2	11351-117H1	26.62	2.05	2.73	0.68	0.00
Melanocyte - light, donor3	11423-118G1	26.88	3.47	3.47	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	55.81	1.67	0.73	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	36.31	1.61	0.27	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	40.71	1.34	0.80	0.27	0.27
Meningeal Cells, donor1	11493-119E8	77.91	2.48	1.74	0.37	0.00
Meningeal Cells, donor2	11573-120E7	54.58	3.96	2.20	0.00	0.00
Meningeal Cells, donor3	11654-122E7	67.24	2.04	0.98	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	44.48	2.00	1.43	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	24.65	1.51	1.71	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	6.57	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	39.47	2.15	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	19.48	2.12	1.06	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	1.01	0.00	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.67	1.10	0.22	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	28.49	2.92	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.28	0.82	1.23	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	23.55	2.35	0.83	0.55	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	0.74	0.00	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.58	2.50	0.66	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	0.89	1.78	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	2.56	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	77.98	1.42	0.71	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.33	0.94	1.88	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	53.70	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	18.03	3.98	1.06	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	22.02	2.00	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	21.90	1.16	0.58	0.07	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	0.00	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.72	1.72	1.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.67	1.77	2.06	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	1.24	1.55	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	3.11	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	19.02	2.00	1.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	2.79	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.65	2.64	1.22	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.54	3.17	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	13.68	3.04	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.70	2.76	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	1.84	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	11.62	1.79	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.05	1.51	1.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.94	1.19	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	4.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	12.89	2.53	0.69	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.47	1.68	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.19	1.22	0.82	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	15.02	2.36	1.29	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	8.45	0.67	1.56	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.61	0.66	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	5.58	1.52	0.51	1.01	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.96	1.36	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	9.12	1.18	0.59	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	1.92	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.01	1.60	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.02	1.00	1.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	23.65	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.34	0.25	0.99	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.91	1.71	0.00	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	16.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.78	0.00	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	22.44	1.12	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	8.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	18.70	0.60	0.60	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	25.46	1.67	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	28.46	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.07	0.28	0.28	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	25.66	1.04	0.52	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.45	0.86	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	0.80	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	0.00	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.58	0.85	0.42	0.14	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.61	2.23	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.08	0.44	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	26.14	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.83	1.23	0.98	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.91	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.82	1.18	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	17.88	0.86	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.54	2.06	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.29	1.19	2.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.37	2.63	0.33	0.33	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.08	2.17	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	2.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.15	1.50	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.92	2.93	1.07	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.55	2.26	0.79	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	1.47	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.95	2.20	0.73	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	14.43	1.60	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	7.73	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.38	2.53	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	10.90	10.90	13.62	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	1.91	6.36	4.45	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.15	7.29	8.10	4.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	1.51	9.06	3.02	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	22.84	17.13	28.55	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	39.15	16.31	32.62	29.36	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	12.55	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.45	2.37	0.65	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	4.70	1.57	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	0.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.51	2.09	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	48.87	4.94	2.28	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	0.00	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	12.86	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.60	0.84	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.62	0.93	0.46	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	1.08	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.24	5.26	6.10	1.68	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	22.27	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	2.48	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.10	2.17	1.35	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.75	1.59	0.91	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.51	1.80	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.40	5.29	4.56	2.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.83	4.24	2.12	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	3.00	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.71	8.86	3.94	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.97	1.46	0.33	1.14	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	8.82	3.88	4.76	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	2.81	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.52	2.76	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.28	1.29	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	23.11	9.66	2.41	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	2.53	5.06	5.06	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.13	4.46	5.12	2.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	7.20	1.27	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.92	3.32	0.71	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	2.15	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	45.14	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.66	1.67	0.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	4.96	2.25	4.06	1.35	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	0.00	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	3.78	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	0.98	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.10	0.44	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	9.05	2.26	1.81	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	2.68	0.38	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.26	3.63	1.81	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.95	3.98	7.07	1.77	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	2.03	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	10.22	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.02	1.22	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.67	0.31	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.26	1.51	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	4.75	6.33	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	22.67	9.07	3.40	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	25.29	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	27.70	1.61	0.75	0.50	0.12
Myoblast, donor2	11322-117D8	25.89	1.34	0.77	0.58	0.00
Myoblast, donor3	11398-118D3	33.80	3.20	1.18	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.44	3.79	1.75	0.73	4.09
Natural Killer Cells, donor1	11230-116C6	15.07	16.91	12.30	5.23	3.69
Natural Killer Cells, donor2	11311-117C6	6.63	25.33	8.75	3.32	3.62
Natural Killer Cells, donor3	11387-118C1	9.94	24.11	12.33	4.23	2.02
Neural stem cells, donor1	11275-116H6	62.06	9.80	5.44	1.09	0.73
Neural stem cells, donor2	11352-117H2	63.55	15.41	1.93	1.93	0.00
Neurons, donor1	11494-119E9	53.48	5.69	5.69	0.00	2.28
Neurons, donor2	11574-120E8	57.68	5.94	2.86	1.54	0.44
Neurons, donor3	11655-122E8	35.35	6.58	1.64	0.82	0.82
Neutrophils, donor1	11233-116C9	2.78	7.42	12.06	1.86	0.00
Neutrophils, donor2	11314-117C9	0.00	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	17.10	6.11	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	28.50	4.04	1.78	1.19	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	10.74	2.60	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	32.69	1.40	0.40	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	15.42	1.79	0.69	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	24.46	1.01	1.30	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	19.30	2.27	1.02	0.11	0.11
Olfactory epithelial cells, donor4	11936-126A1	22.40	1.85	0.68	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	68.01	1.81	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.40	1.49	1.91	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	0.62	1.86	1.24	0.00
Osteoblast, donor1	11277-116H8	48.66	4.50	3.52	1.37	0.39
Osteoblast, donor2	11354-117H4	43.54	3.51	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	29.33	1.78	1.07	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	41.53	3.12	1.94	0.42	0.08
Pericytes, donor1	11491-119E6	7.57	1.67	1.34	0.00	0.00
Pericytes, donor2	11571-120E5	7.02	1.81	0.68	0.23	0.00
Pericytes, donor3	11652-122E5	23.60	0.61	0.41	0.41	0.00
Perineurial Cells, donor1	11499-119F5	53.35	2.26	0.68	0.23	0.11
Perineurial Cells, donor2	11579-120F4	36.99	3.31	1.01	0.46	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	16.89	8.61	3.82	0.96	1.91
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	11.02	8.82	4.16	1.96	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	9.84	4.40	2.07	0.91	0.39
Placental Epithelial Cells, donor1	11278-116H9	28.94	1.91	3.83	1.43	0.24
Placental Epithelial Cells, donor2	11355-117H5	13.31	4.44	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.14	1.18	0.59	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	0.63	0.95	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	16.70	2.44	1.31	1.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	50.78	3.13	0.78	0.13	0.26
Preadipocyte - breast, donor2	11328-117E5	14.86	0.68	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	18.86	3.09	1.81	0.32	0.11
Preadipocyte - omental, donor2	11329-117E6	25.75	2.62	1.75	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	18.34	1.29	1.29	0.14	0.14
Preadipocyte - perirenal, donor1	11469-119C2	14.76	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	43.30	2.46	0.61	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	58.61	0.18	1.42	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	31.50	1.36	0.68	0.34	0.34
Preadipocyte - visceral, donor1	11280-116I2	64.55	2.79	1.58	0.75	0.09
Preadipocyte - visceral, donor2	11357-117H7	25.77	3.68	1.38	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	32.60	1.25	0.63	0.31	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	54.61	3.62	3.02	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	21.94	1.90	0.14	0.41	0.14
Prostate Epithelial Cells, donor3	11404-118D9	23.70	2.14	0.67	0.73	0.12
Prostate Stromal Cells, donor1	11254-116F3	50.12	1.94	1.37	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	37.47	1.79	0.54	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	14.91	1.25	0.83	0.31	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	26.64	1.09	1.09	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.83	2.08	0.55	0.62	0.07
Renal Epithelial Cells, donor1	11517-119H5	13.19	1.52	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	17.07	2.13	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	47.53	2.01	0.85	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	2.04	1.36	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	26.68	1.35	0.40	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	43.74	2.66	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.66	2.66	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	22.45	1.54	0.66	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	22.57	3.13	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.83	0.28	0.28	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	47.24	1.61	0.27	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	22.77	0.42	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.06	1.35	0.19	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	47.71	1.81	0.52	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	48.04	2.84	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	3.09	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	40.90	3.26	1.00	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.78	5.88	2.67	1.60	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	59.86	8.04	1.79	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	156.31	15.41	7.71	2.20	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	70.77	10.44	6.96	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	128.20	7.80	3.38	0.65	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	92.95	7.55	2.18	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	132.06	7.36	4.24	1.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	160.88	11.04	3.47	0.99	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	94.40	6.64	3.15	0.82	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	128.28	7.86	4.16	0.69	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	89.54	5.34	2.88	0.96	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	96.06	7.26	3.93	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	102.68	6.09	1.97	1.08	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	104.01	7.89	3.16	0.86	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	92.93	7.08	2.79	0.86	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	90.94	6.64	1.99	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	84.69	6.50	3.44	1.34	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	87.39	6.99	2.24	0.75	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	124.96	11.27	4.51	1.50	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	100.59	6.64	1.86	1.06	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	94.71	6.42	3.31	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	111.33	6.68	3.44	1.53	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	103.27	6.09	2.56	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	84.93	3.92	2.80	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	97.24	7.69	2.56	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	98.64	4.56	2.73	0.36	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	84.49	5.64	2.70	0.86	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	105.98	7.12	1.75	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	93.41	9.67	4.01	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	94.25	4.76	2.78	0.40	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	101.02	7.02	3.74	0.94	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	97.25	7.88	4.35	0.83	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	81.41	7.52	1.55	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	88.15	5.64	3.13	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	94.61	6.06	2.42	0.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	86.34	4.26	2.21	0.68	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	85.22	5.01	2.31	0.96	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	88.55	7.74	2.24	1.03	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	74.89	4.94	2.19	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	94.73	9.85	3.12	0.66	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	89.82	5.79	2.22	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	105.79	4.73	1.92	0.44	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	84.23	5.33	4.00	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	106.60	7.74	2.49	1.24	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	92.62	6.90	1.90	0.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	89.69	8.06	2.42	1.21	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	82.69	9.13	2.73	1.22	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	85.94	8.04	2.45	0.35	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	72.53	7.56	2.12	1.51	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	90.69	8.20	2.94	0.98	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	137.69	11.35	4.51	1.75	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	93.09	9.13	3.65	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	87.71	7.23	3.32	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	93.19	8.82	4.07	0.45	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	86.57	11.68	3.89	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	119.61	11.69	5.08	2.60	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	86.45	9.39	2.77	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	70.92	10.22	4.21	1.20	0.60
Schwann Cells, donor1	11498-119F4	21.44	1.69	0.94	0.38	0.00
Schwann Cells, donor2	11578-120F3	61.24	6.80	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	24.32	2.63	0.44	0.66	0.00
Sebocyte, donor1	11220-116B5	93.67	3.83	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	49.17	1.38	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	26.38	1.24	0.41	0.62	0.00
Sertoli Cells, donor1	11255-116F4	29.82	3.31	1.66	1.66	1.66
Sertoli Cells, donor2	11333-117F1	31.07	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	50.41	3.87	2.46	1.32	0.18
Skeletal Muscle Cells, donor2	11358-117H8	7.95	7.23	2.89	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	44.31	5.85	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	68.81	1.73	0.79	0.79	0.16
Skeletal Muscle Cells, donor5	11455-119A6	60.94	2.82	0.89	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	77.41	2.77	0.92	0.31	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	55.06	2.52	2.14	0.63	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	32.53	2.43	1.14	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	70.14	2.08	0.89	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	43.39	5.48	1.77	0.42	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	41.98	2.17	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.67	2.34	0.96	0.14	0.14
Skin - palm, donor1	10286-104F7	24.17	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.72	1.44	0.00	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	107.14	8.18	3.27	2.45	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.60	1.30	0.13	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	34.75	2.09	0.42	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	27.29	1.27	0.70	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	129.40	4.44	2.54	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	19.49	1.27	0.37	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	15.43	1.54	0.31	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	45.36	1.78	1.78	0.89	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.80	1.76	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.03	3.09	1.33	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	35.05	3.15	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.90	2.32	0.77	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	2.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.14	1.46	0.67	0.53	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	28.59	1.99	1.55	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.29	2.69	0.90	0.26	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	2.28	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.67	0.59	1.18	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	24.63	0.85	0.28	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.06	0.81	0.65	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.31	1.52	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.29	3.79	1.26	1.52	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	26.23	1.43	0.48	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.73	1.77	0.59	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.52	1.08	1.08	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	32.85	1.68	0.63	0.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	29.08	2.32	1.08	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	26.95	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.30	1.20	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.09	0.68	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	32.83	3.38	0.79	0.71	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	27.27	2.82	1.51	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	27.31	2.05	0.91	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	24.76	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	107.56	2.91	2.12	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.35	2.40	0.93	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.29	1.50	0.75	0.63	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.44	2.03	0.76	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.06	1.96	1.21	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	0.00	2.58	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	21.86	1.40	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	2.02	1.01	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.24	2.82	1.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	0.88	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.56	1.67	1.50	0.33	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.89	0.93	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.38	1.87	1.30	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.93	1.27	1.27	0.76	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.33	1.32	0.94	0.56	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	65.54	1.68	1.40	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	41.31	1.17	0.50	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	1.90	1.43	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.47	1.22	0.49	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.07	1.55	0.44	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.35	2.93	2.34	2.63	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.44	2.92	0.97	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.96	1.06	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.25	4.46	0.00	0.74	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.97	1.80	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.64	0.85	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	27.96	1.58	1.18	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	19.81	4.83	1.27	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	14.77	0.80	1.20	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	2.51	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	17.88	0.92	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	25.08	2.36	0.84	0.84	0.34
Synoviocyte, donor2	11368-117I9	18.77	1.34	0.84	0.50	0.00
Synoviocyte, donor3	11440-118H9	13.18	1.12	0.45	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	21.80	2.50	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.82	1.16	0.23	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	61.08	2.15	0.86	0.65	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	32.86	2.32	0.77	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	46.96	4.58	2.29	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.68	5.17	0.98	0.74	0.37
Urethra, donor2	10319-105A4	17.98	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.64	1.06	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	14.42	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	10.09	1.38	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	52.60	2.01	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	26.69	3.56	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	5.72	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	12.32	4.79	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	32.02	5.51	2.07	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.66	8.13	4.07	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	8.33	1.04	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	28.45	12.85	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	11.87	3.65	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	69.45	4.81	1.73	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	31.68	0.88	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	62.29	0.84	0.28	0.00	0.28
achilles tendon, donor2	10292-104G4	4.13	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	100.20	5.10	1.27	1.02	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	114.46	8.36	2.55	1.39	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	118.35	9.50	1.78	0.59	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	109.39	15.78	4.08	0.82	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	114.40	5.62	1.97	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	53.29	5.71	1.90	0.42	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	58.53	5.44	1.91	0.54	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	89.01	2.20	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	97.60	10.21	4.49	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	82.71	2.72	1.16	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	103.41	5.70	2.76	0.55	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	0.00	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	83.19	4.65	1.16	0.46	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	113.66	10.10	3.62	1.04	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	79.49	6.14	1.75	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.11	3.25	0.93	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	37.84	4.94	2.47	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	25.48	0.92	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	74.25	5.55	0.43	0.85	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	78.55	4.55	3.64	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	76.54	4.33	0.48	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	69.27	3.12	2.00	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	73.71	6.34	1.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	105.92	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	165.35	9.04	3.77	1.88	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	53.21	3.49	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	37.92	4.00	1.18	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	34.75	3.88	0.93	0.47	0.16
adipose, donor1	10184-103D4	75.65	15.83	11.73	2.93	0.00
adipose, donor2	10185-103D5	13.79	4.87	1.62	0.00	0.00
adipose, donor3	10186-103D6	35.13	9.26	5.72	1.36	0.27
adipose, donor4	10187-103D7	78.87	11.27	4.33	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	75.44	6.63	2.37	1.10	0.47
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	85.11	7.20	3.20	1.47	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	65.39	3.93	2.50	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	18.32	3.48	1.39	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	22.31	3.38	1.35	1.35	0.34
amniotic membrane cells, donor3	12237-129G5	13.85	5.30	2.06	0.59	0.29
amygdala - adult, donor10196	10167-103B5	17.79	13.04	4.74	0.00	1.19
amygdala, adult, donor10252	10151-102I7	22.51	10.14	2.84	1.01	1.01
amygdala, newborn, donor10223	10360-105E9	19.37	6.78	5.49	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	32.47	3.69	1.02	1.78	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	65.97	1.99	0.88	0.66	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	85.85	4.68	1.67	0.67	0.67
aorta, adult, pool1	10052-101G7	19.42	2.55	0.98	1.18	0.00
appendix, adult	10189-103D9	32.99	3.49	1.16	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	48.15	8.25	3.10	1.03	0.69
artery, adult	10190-103E1	13.59	4.08	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	48.97	5.65	1.59	0.43	0.14
b cell line:RPMI1788	10427-106D4	49.96	3.87	1.78	0.89	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.58	1.39	0.28	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	85.74	2.58	1.49	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	59.92	2.18	1.51	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	36.35	2.80	0.56	1.12	0.00
bladder, adult, pool1	10011-101C2	28.79	0.87	0.98	0.43	0.00
blood, adult, pool1	10053-101G8	15.50	2.21	2.21	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	14.56	2.57	0.00	0.00	0.00
bone marrow, adult	10192-103E3	26.32	4.05	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	10.25	13.33	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	16.82	7.02	1.78	0.56	0.00
brain, fetal, pool1	10085-102B4	45.41	2.67	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	27.75	6.94	3.96	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.20	8.99	5.49	1.75	1.25
breast, adult, donor1	10080-102A8	25.25	0.63	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	72.16	1.27	1.65	0.13	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	61.53	4.02	0.93	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	71.83	2.53	0.69	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	63.91	3.63	2.18	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	89.33	6.58	4.23	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	50.21	2.30	1.09	0.33	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	71.30	4.12	1.90	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	70.80	3.99	2.66	1.86	0.00
caudate nucleus - adult, donor10196	10177-103C6	16.12	6.91	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	23.93	14.56	3.18	1.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	15.28	5.35	0.76	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	21.97	11.35	6.23	2.20	1.83
cerebellum - adult, donor10196	10173-103C2	46.61	11.65	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	28.61	12.17	4.70	0.43	0.00
cerebellum, adult, pool1	10083-102B2	16.56	4.48	1.72	0.69	1.03
cerebellum, newborn, donor10223	10357-105E6	22.42	30.72	5.81	0.83	1.66
cerebral meninges, adult	10188-103D8	14.37	5.80	1.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	10.23	2.19	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	137.60	3.02	3.31	0.72	0.14
cervical cancer cell line:ME-180	10553-107I4	45.07	3.48	0.99	0.00	0.00
cervix, adult, pool1	10013-101C4	25.62	3.46	0.63	0.10	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.98	3.76	1.39	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	2.61	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	95.69	6.46	3.23	0.99	0.75
choriocarcinoma cell line:SCH	10785-110H2	105.22	4.31	3.57	1.48	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	79.22	5.93	1.90	0.95	0.47
chorionic membrane cells, donor1	12238-129G6	19.37	3.70	3.13	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	37.58	2.29	0.99	0.60	0.10
chorionic membrane cells, donor3	12240-129G8	27.47	6.04	1.65	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	44.43	9.09	1.01	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.77	2.50	0.58	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	141.71	4.43	3.59	0.63	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	172.57	5.91	4.11	1.80	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	186.97	6.05	3.63	2.18	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	190.99	5.90	6.11	1.83	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	209.06	2.94	2.65	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	192.60	3.91	2.09	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	63.55	2.06	0.46	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	27.41	1.39	1.39	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	69.37	6.22	2.20	0.92	0.18
colon carcinoma cell line:COLO-320	10420-106C6	122.77	7.22	4.18	0.76	0.76
colon, adult, donor1	10082-102B1	29.75	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	31.61	2.35	1.18	0.47	0.00
colon, fetal, donor1	10070-101I7	16.69	3.09	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	4.58	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	127.05	9.77	3.82	0.85	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	127.84	6.64	3.47	0.75	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	139.60	6.06	4.23	0.85	0.56
corpus callosum, adult, pool1	10042-101F6	35.60	9.95	4.42	0.55	0.22
cruciate ligament, donor2	10295-104G7	17.02	1.62	1.62	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	15.25	2.41	0.00	0.00	0.80
diencephalon, adult	10193-103E4	18.00	6.96	2.64	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	85.64	8.73	3.21	2.07	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	26.67	2.31	0.77	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	148.28	2.65	1.44	1.69	0.00
ductus deferens, adult	10196-103E7	17.94	6.48	0.50	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.75	2.94	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	26.68	2.15	1.24	0.50	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	117.92	24.21	30.20	20.87	7.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	152.46	8.45	5.45	2.29	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	55.50	0.00	1.85	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	63.27	3.03	0.61	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.12	2.78	1.23	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	63.05	1.31	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	37.88	1.34	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	83.91	2.90	1.63	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	27.98	2.25	0.96	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	78.59	4.89	0.44	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	91.07	3.74	0.99	0.77	0.66
epididymis, adult	10197-103E8	18.00	3.56	0.84	0.00	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.03	2.48	1.77	0.53	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	46.40	1.18	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	117.42	4.32	3.15	0.92	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	122.73	5.12	3.35	0.69	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	121.78	4.26	2.69	0.78	0.34
esophagus, adult, pool1	10015-101C6	28.35	2.23	0.74	0.53	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	103.07	3.26	1.50	0.25	0.25
eye - muscle inferior rectus, donor1	10272-104E2	26.56	2.41	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	12.63	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	4.46	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	18.34	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	17.29	3.56	1.53	0.76	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	93.09	2.82	0.90	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	57.46	2.14	1.19	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	25.90	12.48	3.10	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	82.27	2.70	1.80	1.50	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	59.53	1.46	0.91	0.46	0.09
gall bladder, adult	10198-103E9	20.04	1.21	1.93	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	33.82	10.20	3.22	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	23.16	6.72	1.49	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	72.24	4.65	0.84	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	93.23	2.13	1.16	1.16	0.19
gastric cancer cell line:AZ521	10549-107H9	128.21	5.25	2.95	2.13	0.33
gastric cancer cell line:GSS	10560-108A2	58.57	0.92	4.58	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.60	1.60	1.83	0.46	0.69
giant cell carcinoma cell line:LU65	10487-107B1	83.42	1.72	2.64	1.72	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	47.87	0.84	0.42	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	51.88	3.49	2.99	0.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.79	7.18	3.06	0.63	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.08	7.44	3.79	0.84	0.70
glioblastoma cell line:T98G	10485-107A8	72.40	3.42	3.20	0.99	0.66
glioma cell line:GI-1	10413-106B8	54.18	2.93	3.22	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	20.41	9.48	5.10	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	41.50	17.09	5.13	1.22	0.98
globus pallidus, adult, donor10258	10367-105F7	30.12	21.91	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	17.05	9.06	1.07	2.13	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	5.23	10.45	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.76	3.20	1.60	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	91.82	6.43	2.75	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	91.00	7.32	2.29	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	95.97	4.51	1.93	0.64	0.00
hIPS, biol_rep1	14380-156B6	30.18	7.19	2.87	2.87	0.00
hIPS, biol_rep2	14381-156B7	77.50	1.37	4.12	1.37	0.00
hIPS, biol_rep3	14382-156B8	28.69	8.83	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	56.89	3.16	2.59	0.00	0.00
heart - mitral valve, adult	10205-103F7	23.02	3.89	1.49	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	21.44	3.66	1.57	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	38.30	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	34.49	3.06	0.41	0.41	0.41
heart, adult, diseased, donor1	10051-101G6	20.87	3.41	1.28	0.43	0.00
heart, adult, pool1	10016-101C7	12.88	1.61	1.15	0.23	0.23
heart, fetal, pool1	10046-101G1	37.07	6.88	1.85	0.51	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.67	0.62	1.54	0.31	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	2.38	3.57	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	69.61	6.08	2.87	0.55	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.62	6.43	2.79	0.85	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	78.01	5.66	2.73	1.52	0.40
hepatoma cell line:Li-7	10484-107A7	59.39	1.89	0.78	1.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	106.13	7.44	2.01	0.70	1.91
hippocampus - adult, donor10196	10169-103B7	15.14	13.25	0.95	0.00	1.89
hippocampus, adult, donor10252	10153-102I9	22.86	15.72	3.27	0.61	1.02
hippocampus, adult, donor10258	10374-105G5	18.42	14.44	3.98	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	10.57	8.11	2.47	0.70	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	136.11	14.04	10.38	2.44	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	74.42	4.71	2.75	0.98	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	70.08	5.08	3.81	1.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	7.33	1.13	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	28.66	5.42	3.36	0.77	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	33.41	3.80	3.42	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	37.95	15.18	8.17	2.04	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	33.18	10.13	5.17	0.65	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	35.03	8.34	5.84	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.30	5.92	2.60	0.95	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	41.47	5.30	3.38	1.45	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.84	6.06	2.69	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	76.83	4.54	2.66	1.10	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	93.35	6.39	0.98	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	93.38	7.85	11.35	2.62	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	29.40	6.68	2.29	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.07	5.67	2.18	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	30.49	6.00	5.50	1.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.35	6.22	2.64	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.46	6.82	3.18	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	18.17	7.83	1.88	1.57	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.66	7.19	2.45	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.68	6.68	2.90	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.64	5.08	4.48	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	124.33	8.31	6.84	2.59	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	118.68	7.42	2.28	1.43	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	178.84	19.60	8.17	6.12	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	55.28	9.51	3.17	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	54.16	5.70	2.53	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	48.42	7.57	0.91	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.65	8.79	4.65	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	32.54	11.95	4.65	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.45	9.75	3.59	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	60.84	11.50	4.09	2.05	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	55.28	12.12	3.79	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.74	8.74	4.70	1.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	131.38	9.18	7.73	2.42	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	139.49	10.25	11.59	4.01	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	136.10	11.22	6.83	4.39	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	53.18	4.58	3.67	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	393.64	52.05	19.52	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	74.79	11.58	5.96	1.65	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	56.37	16.97	9.85	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.41	10.49	7.96	3.26	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.08	10.32	7.12	1.78	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	47.74	13.13	2.39	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	87.48	13.00	7.18	2.57	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.11	11.05	6.73	2.42	1.35
immature langerhans cells, donor1	11904-125F5	16.71	8.48	2.42	0.48	0.97
immature langerhans cells, donor2	11905-125F6	29.31	20.60	10.30	3.17	1.58
insula, adult, pool1	10039-101F3	25.27	12.30	3.41	0.95	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	33.49	3.58	1.30	1.63	0.00
kidney, adult, pool1	10017-101C8	29.24	2.70	1.90	0.30	0.00
kidney, fetal, pool1	10045-101F9	36.85	3.96	1.70	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	65.76	2.84	1.56	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	30.69	1.11	0.69	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.69	0.18	0.18	0.37	0.55
left atrium, adult, donor1	10079-102A7	16.89	0.54	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	18.20	1.01	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	77.98	1.09	1.92	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	14.73	1.80	2.16	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	7.07	1.09	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	19.18	1.94	0.97	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	47.05	1.05	2.09	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	232.34	4.49	1.42	0.47	1.30
liposarcoma cell line:KMLS-1	10782-110G8	37.18	4.53	1.87	0.78	0.16
liposarcoma cell line:SW 872	10726-110A6	48.37	6.70	1.95	0.12	0.00
liver, adult, pool1	10018-101C9	38.41	4.21	2.92	0.16	0.00
liver, fetal, pool1	10086-102B5	26.34	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	15.89	7.44	3.94	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	26.21	10.70	4.24	0.55	0.74
locus coeruleus, adult, donor10258	10375-105G6	18.06	7.05	1.97	1.13	0.00
locus coeruleus, newborn, donor10223	10362-105F2	25.66	11.78	5.47	4.63	1.26
lung adenocarcinoma cell line:A549	10499-107C4	31.69	1.11	0.97	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	4.83	0.69	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	60.11	2.24	1.85	0.26	0.13
lung, adult, pool1	10019-101D1	20.20	2.95	0.71	0.47	0.00
lung, fetal, donor1	10068-101I5	41.38	8.85	2.00	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	14.66	2.75	2.29	0.46	0.46
lymph node, adult, donor1	10077-102A5	20.35	1.42	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	58.08	3.51	1.32	0.88	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	102.63	10.72	3.62	0.60	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	99.39	3.40	0.85	0.85	0.00
mature adipocyte, donor1	12231-129F8	26.64	4.00	2.22	0.89	0.00
mature adipocyte, donor2	12232-129F9	30.92	4.36	2.49	0.83	0.62
mature adipocyte, donor3	12233-129G1	37.22	4.03	1.90	1.90	0.24
mature adipocyte, donor4	12234-129G2	47.64	6.32	2.90	1.58	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	91.97	5.48	5.24	0.48	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	3.38	4.51	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	23.72	13.79	3.68	0.92	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	14.93	6.35	1.91	0.64	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	35.40	15.35	9.38	2.99	5.12
medial temporal gyrus - adult, donor10196	10183-103D3	19.41	15.69	2.87	0.51	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	28.23	13.37	5.31	1.27	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	11.56	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	12.56	7.90	3.23	2.87	1.44
medulla oblongata - adult, donor10196	10174-103C3	19.47	7.14	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	23.84	11.61	3.87	0.93	0.46
medulla oblongata, adult, pool1	10038-101F2	26.12	7.26	3.10	1.06	0.33
medulla oblongata, newborn, donor10223	10361-105F1	21.87	5.55	2.43	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	119.78	5.09	2.21	0.66	1.11
medulloblastoma cell line:ONS-76	10759-110E3	50.87	2.93	0.61	0.24	0.49
melanoma cell line:COLO 679	10514-107E1	58.36	2.16	0.00	0.29	0.14
melanoma cell line:G-361	10465-106H6	77.64	2.44	1.09	0.27	0.27
meningioma cell line:HKBMM	10691-109F7	34.73	0.18	0.36	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	77.54	9.69	4.41	5.29	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	82.43	4.15	3.63	2.07	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.24	2.61	1.07	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	41.81	3.82	1.09	0.91	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	29.82	3.73	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.91	2.25	0.70	0.56	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.87	2.31	0.77	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	1.39	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	25.23	1.20	0.69	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.37	2.88	0.81	0.81	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.16	1.86	0.80	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	34.57	1.89	1.62	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	36.42	1.85	0.28	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.44	2.31	0.99	0.66	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	27.81	1.80	0.69	0.42	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	20.94	0.00	1.75	1.40	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.11	0.82	0.20	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.49	0.36	1.08	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.28	1.97	0.52	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.05	0.00	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	50.35	1.26	0.00	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.60	2.84	0.75	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.48	1.93	1.75	0.79	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.25	1.47	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	0.57	1.14	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	35.79	5.47	2.11	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.70	2.28	0.00	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.67	3.07	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	20.68	1.57	1.57	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	17.87	2.46	0.62	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	20.01	2.12	0.71	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.29	2.03	1.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	1.57	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	3.71	0.93	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	20.77	4.04	2.02	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	13.61	3.12	1.56	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.06	3.12	1.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	2.20	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.09	3.02	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	3.68	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	3.87	1.29	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.97	2.27	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	4.36	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.46	3.20	0.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	0.82	3.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.33	3.50	1.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	0.00	2.10	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	1.99	2.98	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	2.37	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	3.66	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	2.53	2.53	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.52	5.17	2.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	6.45	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	7.98	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	2.85	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	2.38	3.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	2.36	1.18	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	14.65	2.81	1.25	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	2.67	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	0.69	1.38	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.71	2.47	0.49	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	6.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	2.54	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	3.22	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	2.18	2.18	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	2.53	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.31	1.21	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	9.04	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	30.48	4.12	3.29	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.29	3.57	1.59	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.36	2.92	0.32	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	4.07	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	2.32	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.59	0.24	0.71	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	60.24	3.48	1.16	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	35.04	3.49	0.82	0.51	0.51
mesothelioma cell line:Mero-25	10850-111F4	102.58	7.72	3.86	1.13	0.68
mesothelioma cell line:Mero-41	10851-111F5	70.41	3.18	1.71	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	39.86	5.76	3.10	0.89	0.00
mesothelioma cell line:Mero-82	10853-111F7	61.23	3.15	2.10	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	93.62	7.66	2.55	0.68	0.51
mesothelioma cell line:Mero-84	10855-111F9	58.90	3.29	1.01	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	45.34	2.90	0.62	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	47.21	4.80	3.81	0.66	0.17
mesothelioma cell line:NCI-H226	10846-111E9	47.42	3.98	1.99	0.18	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	58.59	7.69	3.25	2.05	0.68
mesothelioma cell line:NCI-H28	10845-111E8	53.18	2.54	2.29	0.51	0.51
mesothelioma cell line:No36	10857-111G2	62.96	3.59	1.96	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	40.10	1.90	1.90	0.27	0.81
migratory langerhans cells, donor1	11901-125F2	40.69	2.69	1.15	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	28.33	3.18	1.10	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	31.77	2.87	2.69	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.63	1.96	1.63	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	31.37	1.48	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	60.35	1.38	0.92	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.06	3.62	1.90	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	159.29	9.24	4.62	0.74	0.37
myeloma cell line:PCM6	10474-106I6	74.72	4.74	1.19	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	30.44	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.16	2.94	2.16	1.37	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	39.00	1.67	1.56	1.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.59	2.87	1.18	1.47	0.07
nasal epithelial cells, donor2	12227-129F4	40.30	2.21	2.76	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	77.30	11.73	10.81	2.07	2.07
neuroblastoma cell line:NB-1	10539-107G8	87.93	2.62	0.75	0.56	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	62.84	5.69	1.90	2.11	1.05
neuroblastoma cell line:NH-12	10555-107I6	101.00	8.94	2.98	0.56	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.73	2.61	2.14	0.71	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	62.40	5.23	1.27	1.27	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	96.60	3.62	1.01	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.78	1.91	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	31.67	2.93	0.00	0.53	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	136.48	13.36	4.40	2.37	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	46.43	0.80	3.20	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	20.84	3.21	1.28	0.00	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	18.39	1.84	0.79	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	24.28	11.90	3.75	0.47	0.37
occipital cortex - adult, donor10196	10172-103C1	20.60	14.42	8.24	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	26.03	16.37	3.49	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	15.65	8.01	3.28	1.82	1.82
occipital lobe, adult, donor1	10076-102A4	18.63	10.23	3.41	0.52	0.79
occipital lobe, fetal, donor1	10073-102A1	72.52	13.30	2.15	0.00	1.29
occipital pole, adult, pool1	10036-101E9	20.97	8.12	2.76	0.55	0.63
olfactory region, adult	10195-103E6	17.39	6.88	1.72	0.38	0.38
optic nerve, donor1	10277-104E7	16.01	6.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	74.95	6.38	5.35	1.03	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	109.91	2.61	2.20	0.96	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	38.78	1.02	0.17	0.17	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	56.60	2.43	0.46	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	16.46	1.47	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	62.60	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	93.31	1.48	0.64	0.42	0.21
ovary, adult, pool1	10020-101D2	32.67	1.66	1.05	0.44	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	41.25	1.65	0.37	0.37	0.18
pancreas, adult, donor1	10049-101G4	45.15	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	57.03	1.96	2.24	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	59.11	4.60	2.04	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	55.47	2.98	1.49	0.33	0.33
paracentral gyrus, adult, pool1	10035-101E8	24.25	9.34	3.11	0.73	0.46
parietal cortex, adult, donor10258	10373-105G4	11.74	11.01	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	12.23	11.29	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	24.80	13.40	3.42	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	22.56	11.28	3.35	1.15	0.70
parietal lobe, fetal, donor1	10072-101I9	65.95	22.31	8.73	1.94	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.46	7.48	2.24	2.62	0.75
parotid gland, adult	10199-103F1	20.35	4.93	1.23	0.00	0.00
penis, adult	10200-103F2	15.58	3.22	1.61	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	80.88	2.42	2.42	1.86	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	31.18	1.89	0.44	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	15.48	5.16	3.23	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	31.98	17.17	1.18	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	16.30	6.27	1.25	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	37.44	7.08	2.02	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	55.77	14.59	5.73	4.69	0.52
pituitary gland, adult, donor10258	10378-105G9	17.88	5.11	4.26	1.70	1.70
placenta, adult, pool1	10021-101D3	27.52	4.41	1.94	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	60.25	6.62	3.71	0.93	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.88	3.42	0.78	0.31	0.00
pons, adult, pool1	10033-101E6	28.92	7.57	2.75	0.52	0.95
postcentral gyrus, adult, pool1	10032-101E5	18.05	10.64	3.40	0.35	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	87.25	4.22	1.46	0.87	0.73
prostate cancer cell line:PC-3	10439-106E7	99.28	6.53	2.18	1.27	0.36
prostate, adult, pool1	10022-101D4	26.21	2.00	1.00	0.45	0.18
putamen, adult, donor10196	10176-103C5	17.94	13.93	3.07	1.18	0.24
putamen, adult, donor10252	10152-102I8	31.37	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	34.97	16.39	5.46	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.15	10.87	1.45	0.24	0.24
putamen, newborn, donor10223	10365-105F5	38.98	19.49	3.75	6.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	80.01	4.07	2.62	0.87	0.00
rectum, fetal, donor1	10067-101I4	27.82	2.78	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.46	5.51	2.54	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	51.36	2.07	4.14	1.66	0.00
retina, adult, pool1	10030-101E3	35.09	5.86	1.89	0.60	0.70
retinoblastoma cell line:Y79	10475-106I7	164.45	15.85	9.35	1.56	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	58.65	4.43	0.49	0.37	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	95.61	2.25	1.41	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	14.40	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	48.72	3.72	1.13	0.32	0.16
salivary acinar cells, donor2	11772-123I8	33.46	4.27	2.62	0.55	0.41
salivary acinar cells, donor3	11773-123I9	15.23	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	31.46	7.44	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.00	6.24	4.30	0.76	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.00	7.41	3.06	0.71	0.24
seminal vesicle, adult	10201-103F3	14.81	8.47	2.12	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	51.26	7.53	1.21	0.73	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.34	2.26	0.50	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	23.08	9.03	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.54	2.42	1.07	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	61.67	2.10	1.44	0.77	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.74	2.58	1.55	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	30.50	1.42	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	27.95	4.08	0.48	0.72	0.12
skeletal muscle, fetal, donor1	10066-101I3	15.08	4.02	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.71	7.57	1.26	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.69	6.00	4.34	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	57.37	5.36	2.21	1.89	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	88.47	6.17	4.43	2.12	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	107.14	2.47	3.96	0.99	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	170.18	7.24	7.56	2.73	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	147.09	12.64	3.92	1.09	1.53
small intestine, adult, pool1	10024-101D6	36.91	3.58	1.19	0.36	0.36
small intestine, fetal, donor1	10064-101I1	25.55	2.21	0.74	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	33.85	4.10	2.05	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	24.04	3.10	0.52	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	36.18	2.41	1.88	1.07	0.27
spinal cord - adult, donor10196	10181-103D1	22.48	8.26	2.52	1.15	0.46
spinal cord, adult, donor10252	10159-103A6	21.29	14.98	5.91	1.58	1.18
spinal cord, adult, donor10258	10369-105F9	24.21	18.68	3.46	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	28.66	7.93	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	27.09	8.27	3.21	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.62	1.49	0.30	0.45	0.00
spleen, adult, pool1	10025-101D7	31.06	3.63	1.32	0.00	0.33
spleen, fetal, pool1	10044-101F8	45.85	3.97	1.51	0.24	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	71.53	6.94	1.86	0.52	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	49.75	1.52	0.57	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	43.33	5.24	2.45	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	67.24	1.56	0.39	0.78	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	45.92	5.85	4.05	0.45	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	52.10	2.12	0.42	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	45.69	0.85	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	25.63	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	26.21	3.99	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.04	13.71	4.57	1.25	0.83
substantia nigra, adult, donor10258	10371-105G2	18.10	7.76	4.66	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	9.89	2.83	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	186.62	7.80	3.67	0.46	0.69
temporal lobe, adult, pool1	10031-101E4	18.06	9.32	3.39	0.34	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	56.98	6.41	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	48.79	11.43	1.76	0.88	0.88
tenocyte, donor1	11763-123H8	25.48	2.44	1.40	0.00	0.00
tenocyte, donor2	11765-123I1	12.21	2.29	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	15.57	2.22	0.37	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	148.72	6.97	3.57	0.68	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	77.38	4.32	1.70	1.08	0.62
teratocarcinoma cell line:PA-1	10807-111A6	88.49	3.25	1.24	0.77	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	67.41	1.78	0.51	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	145.22	10.21	3.78	2.27	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	53.66	0.76	0.22	0.11	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	87.29	6.84	7.49	2.61	0.00
testis, adult, pool1	10026-101D8	21.80	14.07	35.33	16.96	1.61
testis, adult, pool2	10096-102C6	17.59	27.52	63.15	25.26	1.35
thalamus - adult, donor10196	10168-103B6	19.87	16.56	3.31	1.10	1.10
thalamus, adult, donor10252	10154-103A1	28.60	17.19	3.91	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	13.86	6.16	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	14.16	6.42	1.48	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	20.71	5.18	1.73	4.03	1.15
throat, adult	10209-103G2	21.97	5.24	0.50	0.50	0.50
throat, fetal, donor1	10061-101H7	24.07	4.57	1.22	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	94.80	9.34	3.38	0.20	0.79
thymus, adult, pool1	10027-101D9	63.13	9.64	2.58	0.60	0.70
thymus, fetal, pool1	10043-101F7	53.93	8.42	2.91	2.08	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	50.79	2.66	1.06	0.40	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	73.34	1.96	1.40	0.56	0.42
thyroid, adult, pool1	10028-101E1	33.22	5.32	1.12	0.28	0.19
thyroid, fetal, donor1	10060-101H6	21.62	4.48	1.05	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	26.51	3.02	0.70	0.00	0.00
tongue, fetal, donor1	10059-101H5	22.86	5.91	0.39	0.79	0.39
tonsil, adult, pool1	10047-101G2	52.79	5.31	0.60	0.40	0.10
trachea, adult, pool1	10029-101E2	37.87	1.80	1.31	0.57	0.08
trachea, fetal, donor1	10058-101H4	27.70	1.92	1.15	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	29.76	0.71	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	116.51	7.40	3.44	1.42	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	155.43	1.57	1.88	0.31	0.16
tridermal teratoma cell line:HGRT	10694-109G1	15.22	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.06	1.10	1.44	0.25	0.08
umbilical cord, fetal, donor1	10057-101H3	31.30	8.35	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	40.44	6.65	0.68	0.68	0.17
uterus, fetal, donor1	10055-101H1	34.81	3.58	2.05	0.00	0.51
vagina, adult	10204-103F6	14.86	1.94	0.65	0.65	0.00
vein, adult	10191-103E2	21.04	2.85	0.22	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	3.20	1.07	0.27	0.00